Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$69.0 million and is expected to close on March 29, 2022.

The offering consists of 4.6 million common shares, upsized from 4.0 million shares, selling at US$15.00 per share. The company intends to use the proceeds to fund the clinical development and expansion of its drug candidate epetraborole, and for general corporate purposes, including working capital and operating expenses.

Cowen, SVB Leerink, and Evercore ISI act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 690,000 shares at the same IPO price.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The Menlo Park-based biotech company is focused on developing epetraborole, an experimental oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

LOGO

Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Electric Vehicle SPAC Arogo Capital Acquisition Prices Downsized US$90 Million IPO

Special purpose acquisition company Arogo Capital Acquisition Corp. (Nasdaq: AOGOU) will start on Monday to...

Friday, December 24, 2021, 02:46:00 PM

VerticalScope Issues 5.7 Million Shares, Raises $125.1 Million In Initial Public Offering

Toronto-based tech firm VerticalScope Holdings Inc. (TSX: FORA) closed its initial public offering today, raising...

Monday, June 21, 2021, 10:55:00 AM

Biotech SPAC Larkspur Health Acquisition Prices US$75 Million IPO

After filing for registration in May 2021, special purpose acquisition company Larkspur Health Acquisition Corp....

Tuesday, December 21, 2021, 01:54:00 PM

Did Nasdaq Rewrite Its Index Rules for SpaceX?

Nasdaq adopted a sweeping overhaul of its Nasdaq-100 methodology in March 2026, effective May 1...

Monday, June 1, 2026, 05:43:36 AM

Chinese Investment Firm-Backed Tech SPAC Keyarch Acquisition Prices US$100 Million IPO

Special purpose acquisition company Keyarch Acquisition Corporation (Nasdaq: KYCHU) started trading its securities on the...

Tuesday, January 25, 2022, 02:22:00 PM